pat_auckland said:Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 4 attempts.
pat_auckland said:...my insurance denied cost and coverage coverage because...
Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:
- Document medical necessity (BMI, comorbidities, failed alternatives)
- Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
- Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
- Request peer-to-peer review between your doctor and the plan's medical director
- File external appeal with your state insurance department if internal appeal fails
Don't accept the first denial. The appeal process exists for a reason.
labquiet_amy said:Dr.SurgeonPGH said: ...regarding the discontinuation data for cost and coverage...
This answered a question I did not know how to ask. I will report back once I have actually tried it.
pat_auckland said:Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 4 attempts.
My insurance denied my PA related to cost and coverage. Has anyone successfully appealed? I'm considering going compounded instead.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsSarahChen_PharmD said:The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…
Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:
- Prior authorization appeal with peer-to-peer review
- Manufacturer copay card (for commercial insurance)
- Patient assistance programs (Novo Nordisk, Eli Lilly)
- Compounded medication from a 503B pharmacy ($112/month)
- Canadian pharmacy (requires prescription, ~40-60% savings)
Don't let cost prevent access to effective treatment. There are options at every price point.
Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.